Requip And Migraine

Featured Article

A generic version of Requip for the treatment of restless leg syndrome will soon be available. The Food and Drug Administration gave permission to four companies to manufacture ropinirole hydrochloride in 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg doses. The generic version was approved only for restless legs syndrome, not for treatment of Parkinson's which the brand name drug can be used to treat.

Read more

More information on "Requip And Migraine"

From Our Experts

See more SharePosts »

From Our Sources

More on Migraine »

8 Things You Didn't Know About Restless Legs Syndrome

Researchernih

Fibromyalgia and RLS A 2010 study showed that people with fibromyalgia (FM) are 11 times more likely to have restless legs syndrome (RLS) than the general population.  One-third (33%) of those with FM had RLS as opposed to only 3% of those who...